Which patients with myelofibrosis should receive ruxolitinib therapy?: ELN-SIE evidence-based recommendations - Marchetti, Marco; Hehlmann, Rüdiger (Leukemia, 2017)
Published 14 October 2016
Gesehen am01.10.2018